| Rachelle Bird, LCSW | |
|
1300 E Center St, Provo, UT 84606-3554 | |
| (801) 344-4400 | |
| Not Available |
| Full Name | Rachelle Bird |
|---|---|
| Gender | Female |
| Speciality | Social Worker - Clinical |
| Location | 1300 E Center St, Provo, Utah |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1205488566 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1041C0700X | Social Worker - Clinical | 10375283-35202 (Utah) | Primary |
| Entity Name | State Of Utah |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1811978620 PECOS PAC ID: 6800797333 Enrollment ID: O20040117000195 |
News Archive
The Biomarkers Consortium, a unique public-private partnership that includes the U.S. Food and Drug Administration (FDA), the National Institutes of Health (NIH), and major pharmaceutical companies, led by the Foundation for the National Institutes of Health (FNIH), today announced the launch of a highly anticipated clinical trial to help screen promising new drugs being developed for women with high risk, fast-growing breast cancers—women for whom an improvement over standard treatment could dramatically change the odds of survival.
Asterand plc, a leading provider of human tissue and human tissue-based services to pharmaceutical and biotechnology companies engaged in drug discovery research, today announced that it has extended its collaboration with Bristol-Myers Squibb Company (NYSE: BMY) for access to Asterand's products and services for up to three years.
NOXXON Pharma AG, the biopharmaceutical company focusing on the development of novel drugs based on its unique proprietary Spiegelmer® technology, announced today the successful initial dosing of healthy volunteers in a first-in-human clinical trial with Spiegelmer® NOX-A12. NOX-A12 is NOXXON's second drug candidate entering the clinical stage of development within only five months.
The Allergy Centre of the Charité-Universitätsmedizin Berlin will host three international scientific conferences in the upcoming week. According to Prof. Marcus Maurer, Associate Director of the Allergy Centre at the Clinic for Dermatology, Venereology and Allergology: "Allergological issues have been gaining in importance among clinical physicians." Prof. Mauer explains that all three conferences are focused on enabling scientific exchange about basic allergy research: "Our intent is to offer clinical physicians the opportunity to learn something about the cells, the basis for allergological illnesses.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Rachelle Bird, LCSW Po Box 270, Provo, UT 84603-0270 Ph: (801) 344-4400 | Rachelle Bird, LCSW 1300 E Center St, Provo, UT 84606-3554 Ph: (801) 344-4400 |
News Archive
The Biomarkers Consortium, a unique public-private partnership that includes the U.S. Food and Drug Administration (FDA), the National Institutes of Health (NIH), and major pharmaceutical companies, led by the Foundation for the National Institutes of Health (FNIH), today announced the launch of a highly anticipated clinical trial to help screen promising new drugs being developed for women with high risk, fast-growing breast cancers—women for whom an improvement over standard treatment could dramatically change the odds of survival.
Asterand plc, a leading provider of human tissue and human tissue-based services to pharmaceutical and biotechnology companies engaged in drug discovery research, today announced that it has extended its collaboration with Bristol-Myers Squibb Company (NYSE: BMY) for access to Asterand's products and services for up to three years.
NOXXON Pharma AG, the biopharmaceutical company focusing on the development of novel drugs based on its unique proprietary Spiegelmer® technology, announced today the successful initial dosing of healthy volunteers in a first-in-human clinical trial with Spiegelmer® NOX-A12. NOX-A12 is NOXXON's second drug candidate entering the clinical stage of development within only five months.
The Allergy Centre of the Charité-Universitätsmedizin Berlin will host three international scientific conferences in the upcoming week. According to Prof. Marcus Maurer, Associate Director of the Allergy Centre at the Clinic for Dermatology, Venereology and Allergology: "Allergological issues have been gaining in importance among clinical physicians." Prof. Mauer explains that all three conferences are focused on enabling scientific exchange about basic allergy research: "Our intent is to offer clinical physicians the opportunity to learn something about the cells, the basis for allergological illnesses.
› Verified 7 days ago
Dallas Bean, Clinical Social Worker Medicare: Accepting Medicare Assignments Practice Location: 750 N 200 W Ste 300, Provo, UT 84601 Phone: 801-373-4760 | |
Brenna Garrett, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 1300 E Center St, Provo, UT 84606 Phone: 801-344-4400 | |
Mrs. Karen Dee Amsden, LCSW Clinical Social Worker Medicare: Accepting Medicare Assignments Practice Location: 750 N Freedom Blvd, Provo, UT 84601 Phone: 801-373-4760 | |
Mr. John Paul Lilly, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 286 S 600 E, Suite C, Provo, UT 84606 Phone: 801-377-8232 Fax: 801-377-0930 | |
Frederick Brewer, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 750 N Freedom Blvd, Suite 108, Provo, UT 84601 Phone: 801-373-7394 | |
William Kory Camp, LCSW Clinical Social Worker Medicare: Accepting Medicare Assignments Practice Location: 1300 E Center St, Provo, UT 84606 Phone: 801-344-4215 | |
Alaina Barrick, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 4045 N Canyon Rd, Provo, UT 84604 Phone: 859-582-0032 |